BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Greve KB, Pøhl M, Olsen KE, Nielsen O, Ditzel HJ, Gjerstorff MF. SSX2-4 expression in early-stage non-small cell lung cancer. Tissue Antigens 2014;83:344-9. [PMID: 24645645 DOI: 10.1111/tan.12340] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Iacobas S, Iacobas DA. A Personalized Genomics Approach of the Prostate Cancer. Cells 2021;10:1644. [PMID: 34209090 DOI: 10.3390/cells10071644] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Jian W, Li X, Kang J, Lei Y, Bai Y, Xue Y. Antitumor effect of recombinant Mycobacterium smegmatis expressing MAGEA3 and SSX2 fusion proteins. Exp Ther Med 2018;16:2160-6. [PMID: 30186454 DOI: 10.3892/etm.2018.6425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Greve KB, Lindgreen JN, Terp MG, Pedersen CB, Schmidt S, Mollenhauer J, Kristensen SB, Andersen RS, Relster MM, Ditzel HJ, Gjerstorff MF. Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability. Mol Oncol 2015;9:437-49. [PMID: 25363656 DOI: 10.1016/j.molonc.2014.09.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
4 Johansen S, Gjerstorff MF. Interaction between Polycomb and SSX Proteins in Pericentromeric Heterochromatin Function and Its Implication in Cancer. Cells 2020;9:E226. [PMID: 31963307 DOI: 10.3390/cells9010226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Gjerstorff MF. Novel Insights Into Epigenetic Reprogramming and Destabilization of Pericentromeric Heterochromatin in Cancer. Front Oncol 2020;10:594163. [PMID: 33251148 DOI: 10.3389/fonc.2020.594163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Gjerstorff MF, Andersen MH, Ditzel HJ. Oncogenic cancer/testis antigens: prime candidates for immunotherapy. Oncotarget 2015;6:15772-87. [PMID: 26158218 DOI: 10.18632/oncotarget.4694] [Cited by in Crossref: 170] [Cited by in F6Publishing: 161] [Article Influence: 28.3] [Reference Citation Analysis]
7 Traynor S, Jakobsen ND, Ebbesen MF, Bennedsen SN, Johansen S, Ebstrup ML, Pedersen CB, Ditzel HJ, Brewer JR, Gjerstorff MF. SSX2 promotes the formation of a novel type of intranuclear lamin bodies. Int J Biochem Cell Biol 2022;142:106121. [PMID: 34808373 DOI: 10.1016/j.biocel.2021.106121] [Reference Citation Analysis]
8 Abd Hamid M, Colin-York H, Khalid-Alham N, Browne M, Cerundolo L, Chen JL, Yao X, Rosendo-Machado S, Waugh C, Maldonado-Perez D, Bowes E, Verrill C, Cerundolo V, Conlon CP, Fritzsche M, Peng Y, Dong T. Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses. Cancer Immunol Res 2020;8:203-16. [PMID: 31771983 DOI: 10.1158/2326-6066.CIR-19-0554] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Pan R, Wang Z, Wang X, Fang R, Xia Q, Rao Q. CRTC1-SS18 Fusion Sarcoma With Aberrant Anaplastic Lymphoma Kinase Expression. Int J Surg Pathol 2021;:10668969211021997. [PMID: 34057377 DOI: 10.1177/10668969211021997] [Reference Citation Analysis]
10 Jakobsen MK, Traynor S, Stæhr M, Duijf PG, Nielsen AY, Terp MG, Pedersen CB, Guldberg P, Ditzel HJ, Gjerstorff MF. The Cancer/Testis Antigen Gene VCX2 Is Rarely Expressed in Malignancies but Can Be Epigenetically Activated Using DNA Methyltransferase and Histone Deacetylase Inhibitors. Front Oncol 2020;10:584024. [PMID: 33634013 DOI: 10.3389/fonc.2020.584024] [Reference Citation Analysis]
11 Traynor S, Møllegaard NE, Jørgensen MG, Brückmann NH, Pedersen CB, Terp MG, Johansen S, Dejardin J, Ditzel HJ, Gjerstorff MF. Remodeling and destabilization of chromosome 1 pericentromeric heterochromatin by SSX proteins. Nucleic Acids Res 2019;47:6668-84. [PMID: 31114908 DOI: 10.1093/nar/gkz396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
12 Abd Hamid M, Peng Y, Dong T. Human cancer germline antigen-specific cytotoxic T cell-what can we learn from patient. Cell Mol Immunol 2020;17:684-92. [PMID: 32451453 DOI: 10.1038/s41423-020-0468-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
13 Hutchison S, Pritchard AL. Identifying neoantigens for use in immunotherapy. Mamm Genome 2018;29:714-30. [PMID: 30167844 DOI: 10.1007/s00335-018-9771-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
14 Brückmann NH, Bennedsen SN, Duijf PHG, Terp MG, Thomassen M, Larsen M, Pedersen CB, Kruse T, Alcaraz N, Ditzel HJ, Gjerstorff MF. A functional genetic screen identifies the Mediator complex as essential for SSX2-induced senescence. Cell Death Dis 2019;10:841. [PMID: 31695025 DOI: 10.1038/s41419-019-2068-1] [Reference Citation Analysis]
15 Townsend MH, Shrestha G, Robison RA, O'Neill KL. The expansion of targetable biomarkers for CAR T cell therapy. J Exp Clin Cancer Res 2018;37:163. [PMID: 30031396 DOI: 10.1186/s13046-018-0817-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 10.5] [Reference Citation Analysis]